3.連結財務諸表及び主な注記
(1)連結貸借対照表
| | (単位:百万円) |
| 前連結会計年度 (2024年3月31日) | 当連結会計年度 (2025年3月31日) |
資産の部 | | |
流動資産 | | |
現金及び預金 | 18,756 | 13,196 |
売掛金及び契約資産 | 14,934 | 12,236 |
商品及び製品 | 2,111 | 2,571 |
仕掛品 | 6,220 | 6,388 |
原材料及び貯蔵品 | 12,602 | 12,799 |
その他 | 2,955 | 3,866 |
流動資産合計 | 57,581 | 51,056 |
固定資産 | | |
有形固定資産 | | |
建物及び構築物(純額) | 14,140 | 13,229 |
機械装置及び運搬具(純額) | 3,293 | 2,451 |
土地 | 10,587 | 10,587 |
建設仮勘定 | 171 | 9,495 |
その他(純額) | 1,847 | 1,645 |
有形固定資産合計 | 30,040 | 37,410 |
無形固定資産 | | |
特許権 | 2,158 | 1,881 |
その他 | 1,338 | 1,079 |
無形固定資産合計 | 3,496 | 2,960 |
投資その他の資産 | | |
投資有価証券 | 9,120 | 9,629 |
退職給付に係る資産 | 333 | 307 |
繰延税金資産 | 1,288 | 2,985 |
その他 | 369 | 510 |
貸倒引当金 | △4 | △4 |
投資その他の資産合計 | 11,107 | 13,427 |
固定資産合計 | 44,644 | 53,798 |
資産合計 | 102,226 | 104,855 |
| | (単位:百万円) |
| 前連結会計年度 (2024年3月31日) | 当連結会計年度 (2025年3月31日) |
負債の部 | | |
流動負債 | | |
買掛金 | 890 | 590 |
短期借入金 | 8,200 | 23,005 |
1年内返済予定の長期借入金 | 750 | 3,050 |
未払金 | 2,745 | 3,061 |
未払法人税等 | 1,657 | 36 |
圧縮未決算特別勘定 | 11,996 | 11,996 |
賞与引当金 | 1,016 | 1,089 |
役員賞与引当金 | 114 | 127 |
その他 | 2,765 | 1,032 |
流動負債合計 | 30,135 | 43,988 |
固定負債 | | |
長期借入金 | 14,350 | 12,050 |
従業員株式給付引当金 | 81 | 120 |
退職給付に係る負債 | 903 | 966 |
その他 | 280 | 294 |
固定負債合計 | 15,615 | 13,431 |
負債合計 | 45,750 | 57,420 |
純資産の部 | | |
株主資本 | | |
資本金 | 9,061 | 9,061 |
資本剰余金 | 10,384 | 10,392 |
利益剰余金 | 37,278 | 31,191 |
自己株式 | △2,963 | △5,066 |
株主資本合計 | 53,761 | 45,579 |
その他の包括利益累計額 | | |
その他有価証券評価差額金 | 741 | 937 |
繰延ヘッジ損益 | △0 | 2 |
為替換算調整勘定 | 731 | 393 |
退職給付に係る調整累計額 | 132 | 53 |
その他の包括利益累計額合計 | 1,604 | 1,387 |
新株予約権 | 812 | 75 |
非支配株主持分 | 297 | 392 |
純資産合計 | 56,475 | 47,435 |
負債純資産合計 | 102,226 | 104,855 |
E0097345520JCRファーマ株式会社JCR Pharmaceuticals Co.,Ltd.通期第1号参考様式 [日本基準](連結)Japan GAAPtrueCTECTE2024-04-012025-03-31FY2025-03-312023-04-012024-03-312024-03-311falsefalsefalse455202023-04-012024-03-31jppfs_cor:ValuationDifferenceOnAvailableForSaleSecuritiesMember455202023-04-012024-03-31jppfs_cor:ShareholdersEquityMember455202023-04-012024-03-31jppfs_cor:TreasuryStockMember455202023-04-012024-03-31jppfs_cor:RetainedEarningsMember455202023-04-012024-03-31jppfs_cor:CapitalSurplusMember455202025-03-31jppfs_cor:ValuationAndTranslationAdjustmentsMember455202025-03-31jppfs_cor:RemeasurementsOfDefinedBenefitPlansMember455202025-03-31jppfs_cor:ForeignCurrencyTranslationAdjustmentMember455202025-03-31jppfs_cor:DeferredGainsOrLossesOnHedgesMember455202025-03-31jppfs_cor:ValuationDifferenceOnAvailableForSaleSecuritiesMember455202025-03-31jppfs_cor:ShareholdersEquityMember455202025-03-31jppfs_cor:TreasuryStockMember455202023-04-012024-03-31jppfs_cor:CapitalStockMember455202023-03-31jppfs_cor:NonControllingInterestsMember455202023-03-31jppfs_cor:SubscriptionRightsToSharesMember455202023-03-31jppfs_cor:ValuationAndTranslationAdjustmentsMember455202023-03-31jppfs_cor:RemeasurementsOfDefinedBenefitPlansMember455202023-03-31jppfs_cor:ForeignCurrencyTranslationAdjustmentMember455202023-03-31jppfs_cor:DeferredGainsOrLossesOnHedgesMember455202023-03-31jppfs_cor:ValuationDifferenceOnAvailableForSaleSecuritiesMember455202023-03-31jppfs_cor:ShareholdersEquityMember455202023-03-31jppfs_cor:TreasuryStockMember455202023-03-31jppfs_cor:RetainedEarningsMember455202023-03-31jppfs_cor:CapitalSurplusMember455202023-03-31jppfs_cor:CapitalStockMember455202025-03-31jppfs_cor:RetainedEarningsMember455202024-04-012025-03-31jppfs_cor:RemeasurementsOfDefinedBenefitPlansMember455202024-04-012025-03-31jppfs_cor:ForeignCurrencyTranslationAdjustmentMember455202024-04-012025-03-31jppfs_cor:DeferredGainsOrLossesOnHedgesMember455202024-04-012025-03-31jppfs_cor:ValuationDifferenceOnAvailableForSaleSecuritiesMember455202024-04-012025-03-31jppfs_cor:ShareholdersEquityMember455202024-04-012025-03-31jppfs_cor:TreasuryStockMember455202024-04-012025-03-31jppfs_cor:RetainedEarningsMember455202024-04-012025-03-31jppfs_cor:CapitalSurplusMember455202024-04-012025-03-31jppfs_cor:CapitalStockMember455202024-03-31jppfs_cor:SubscriptionRightsToSharesMember455202024-03-31jppfs_cor:ValuationAndTranslationAdjustmentsMember455202024-03-31jppfs_cor:RemeasurementsOfDefinedBenefitPlansMember455202024-03-31jppfs_cor:ForeignCurrencyTranslationAdjustmentMember455202024-03-31jppfs_cor:DeferredGainsOrLossesOnHedgesMember455202024-03-31jppfs_cor:ValuationDifferenceOnAvailableForSaleSecuritiesMember455202024-03-31jppfs_cor:ShareholdersEquityMember455202024-03-31jppfs_cor:TreasuryStockMember455202024-03-31jppfs_cor:RetainedEarningsMember455202024-03-31jppfs_cor:CapitalSurplusMember455202024-03-31jppfs_cor:CapitalStockMember455202023-04-012024-03-31jppfs_cor:NonControllingInterestsMember455202023-04-012024-03-31jppfs_cor:SubscriptionRightsToSharesMember455202023-04-012024-03-31jppfs_cor:ValuationAndTranslationAdjustmentsMember455202023-04-012024-03-31jppfs_cor:RemeasurementsOfDefinedBenefitPlansMember455202023-04-012024-03-31jppfs_cor:ForeignCurrencyTranslationAdjustmentMember455202023-04-012024-03-31jppfs_cor:DeferredGainsOrLossesOnHedgesMember455202025-03-31jppfs_cor:CapitalSurplusMember455202025-03-31jppfs_cor:CapitalStockMember455202024-04-012025-03-31jppfs_cor:NonControllingInterestsMember455202024-04-012025-03-31jppfs_cor:SubscriptionRightsToSharesMember455202024-04-012025-03-31jppfs_cor:ValuationAndTranslationAdjustmentsMember455202024-03-31jppfs_cor:NonControllingInterestsMember455202025-03-31jppfs_cor:NonControllingInterestsMember455202025-03-31jppfs_cor:SubscriptionRightsToSharesMember455202025-05-13455202025-03-31455202024-04-012025-03-31455202024-03-31455202023-04-012024-03-31455202023-03-31xbrli:pureiso4217:JPY